Today: 22 March 2026
Subscribe
Browse Category

Dividends 24 February 2026 - 2 March 2026

NGX Group dividend and bonus plan jolts the stock — what Nigeria’s market watches this week

NGX Group dividend and bonus plan jolts the stock — what Nigeria’s market watches this week

NGX Group shares jumped 9.8% Friday to 124 naira after posting a 44% rise in 2025 operating profit and declaring a 3 naira full-year dividend plus a 1-for-3 bonus issue. The NGX All Share Index ended February up 23.9% year-to-date at 192,826.78 points, with market capitalisation at 123.76 trillion naira. The market reopens Monday after the weekend closure.
1 March 2026
··
UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline

UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline

UnitedHealth Group shares rose 1.72% to $291.60 by 11:44 a.m. EST Friday, outperforming a weaker market. The company authorized a $2.21 quarterly dividend, payable March 17. Medicare Advantage enrollment fell in seven states for 2026, with UnitedHealth’s count down over 5% but still leading at 9.3 million. The final 2027 Medicare Advantage rate announcement is expected by April 6.
27 February 2026
··
Telstra share price ends higher on buyback filing as dividend timeline sharpens focus

Telstra share price ends higher on buyback filing as dividend timeline sharpens focus

Telstra shares closed up 0.8% at A$5.18 Friday after the company bought back nearly 1.9 million shares for A$9.9 million, part of a buyback now totaling A$671 million. The stock traded ex-dividend this week, with a 10.5 cent interim payout due March 27. The S&P/ASX 200 rose 0.25%. Telstra recently raised its buyback cap to A$1.25 billion following a strong earnings report.
27 February 2026
···
Unilever share price drops in early London trade as ULVR turns ex-dividend

Unilever share price drops in early London trade as ULVR turns ex-dividend

Unilever shares fell 0.7% to 5,365 pence in early London trading after going ex-dividend, removing entitlement to the 40.52 pence Q4 payout. The record date is Feb. 27, with cash due April 10. Investors are watching for the company’s Q1 trading statement on April 30. Unilever recently forecast 2026 sales growth at the low end of its range and announced a €1.5 billion buyback.
26 February 2026
··
Woolworths share price rises again after profit beat; dividend dates and Coles results in focus

Woolworths share price rises again after profit beat; dividend dates and Coles results in focus

Woolworths shares closed up 0.72% at A$36.35 after reporting a 16% rise in first-half underlying net profit to A$859 million, beating estimates. The company raised its full-year earnings outlook and declared a 45-cent fully franked interim dividend. Statutory profit fell 49% to A$374 million after significant items. Investors await Coles’ results on Friday.
26 February 2026
···
Wesfarmers share price drops as ASX hits record; dividend clock and filings in focus

Wesfarmers share price drops as ASX hits record; dividend clock and filings in focus

Wesfarmers shares fell 1.36% to A$79.99 Wednesday, underperforming as the S&P/ASX 200 hit a record high. The company set February 25 as the record date for its 102-cent fully franked interim dividend, payable March 31. Director equity-plan conversions totaling 969 shares were disclosed in filings. Australia’s core inflation remained above target in January, fueling rate-hike speculation.
25 February 2026
··
Woodside share price rises again as dividend lift and CEO hunt keep WDS in focus

Woodside share price rises again as dividend lift and CEO hunt keep WDS in focus

Woodside shares closed up 1.8% at A$28.24 on Wednesday, rising about 4% over two sessions after full-year results and a dividend update. Net profit fell 24% to $2.718 billion, while operating cash flow reached $7.2 billion. The company guided to 2026 production of 172–186 million barrels of oil equivalent and capital spending of $4.0–$4.5 billion. Investors await news on the CEO appointment and progress on LNG projects.
25 February 2026
···
AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
···
Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold shares closed up 6.25% in Toronto on Monday after the company declared its first quarterly dividend and applied for a share buyback. U.S.-listed shares last traded at $17.85, up about 6% after hours. The company reported net debt of $75 million at Jan. 31 after reducing debt by $1.1 billion since mid-2025. Gold prices fell over 1% on Tuesday, posing a near-term challenge for miners.
24 February 2026
···
Wesfarmers share price drops on ex-dividend day — what investors watch next

Wesfarmers share price drops on ex-dividend day — what investors watch next

Wesfarmers shares fell 1.8% to A$81.09 on Tuesday, extending a week-long slide as the stock traded ex-dividend for its A$1.02 interim payout. The record date for the fully franked dividend is Wednesday. The S&P/ASX 200 closed down 0.04%, with consumer discretionary stocks weaker. Wesfarmers has faced pressure since reporting higher profit but warning on costs last week.
24 February 2026
···
1 2 3 4 … 40

Stock Market Today

  • Pro Medicus (ASX:PME) Valuation Faces Mixed Signals After Leadership Changes
    March 22, 2026, 12:50 AM EDT. Pro Medicus (ASX:PME) has restructured its senior leadership, appointing Danny English as CFO and moving Clayton Hatch to combined operational roles. The stock trades at A$120.06, down 2.09% in one day and 46.07% year-to-date, despite a strong 5-year total return of 173.62%. Analysts suggest the company is 39% undervalued with a fair value at A$196.78, citing steady revenue growth and expanding market potential. However, its high price-to-earnings (P/E) ratio of 53.4x exceeds peers and fair estimates, posing a valuation risk if growth expectations are not met. Key risks include accelerated AI adoption in imaging and contract delays with U.S. hospitals. Investors face a split market sentiment on PME's true value amid recent leadership changes and performance concerns.
Go toTop